Integrity of liposomes in presence of cyclodextrins: Effect of liposome type and lipid composition

International Journal of Pharmaceutics

Volumn 333, Issue 1-2, 2007, Pages 167-176

  Hatzi, Panayiota ^a   Mourtas, Spyridon ^a   G Klepetsanis, Pavlos ^a,b   Antimisiaris, Sophia G ^a  

^a School of Health Sciences   (Greece)

^b INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Composition; Cyclodextrin; Lipid; Liposome; Membrane; Membrane integrity; Stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CALCEIN; CHOLESTEROL; CYCLODEXTRIN DERIVATIVE; HYDROXYPROPYL GAMMA CYCLODEXTRIN; LIPOSOME; METHYL BETA CYCLODEXTRIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; LIPID COMPOSITION; LIPID MEMBRANE; LIPID VESICLE; MICELLE; MOLECULAR INTERACTION; PRIORITY JOURNAL; SOLUBILIZATION; TURBIDITY;

BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CYCLODEXTRINS; DRUG COMPOUNDING; EXCIPIENTS; FLUORESCEINS; FLUORESCENT DYES; GAMMA-CYCLODEXTRINS; LIPIDS; LIPOSOMES; MEMBRANE FLUIDITY; NANOTECHNOLOGY; NEPHELOMETRY AND TURBIDIMETRY; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 33847105481     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.059     Document Type: Article

References (21)

1. Boulmedarat L., Piel G., Bochot A., Lesieur S., Delattre L., and Fattal E. Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharm. Res. 22 (2005) 962-971
2. Debouzy J.C., Fauvelle F., Crouzy S., Girault L., Chapron Y., Goschl M., and Gadelle A. Mechanism of a-cyclodextrin induced hemolysis. 2. A study of the factors controlling the association with serine-, ethanolamine-, and choline-phospholipids. J. Pharm. Sci. 87 (1998) 59-66
3. Fatouros D., Haztidimitriou K., and Antimisiaris S.G. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release. Eur. J. Pharm. Sci. 13 (2001) 287-296
4. Fauvelle F., Debouzy J.C., Crouzy S., Goschl M., and Chapron Y. Mechanism of a-cyclodextrin induced hemolysis. 1. The two-step extracton of phosphatidylinositol from the membrane. J. Pharm. Sci. 86 (1997) 935-943
5. Frank S.G. Inclusion compounds. J. Pharm. Sci. 64 (1975) 1585-1604
6. Hagiwara Y., Arima H., Miyamoto Y., Hirayama F., and Uekama K. Preparation and pharmaceutical evaluation of liposomes entrapping salicylic acid/γ-cyclodextrin conjugate. Chem. Pharm. Bull. 54 (2006) 26-32
7. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., and Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270 (1995) 17250-17256
8. Kirby C., and Gregoriadis G. The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice. Biochem. Pharmacol. 32 (1983) 609-615
9. Kirby C., and Gregoriadis G. Dehydration-rehydration vesicles (DRV): a new method for high yield drug entrapment in liposomes. Biotechnology 2 (1984) 979-984
10. Kokkona M., Kallinteri P., Fatouros D., and Antimisiaris S.G. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur. J. Pharm. Sci. 9 (2000) 245-252
11. Loftsson T., and Brewster M.E. Pharmaceutical application of cyclodextrins. 1. Drug solubilization and stability. J. Pharm. Sci. 85 (1996) 1017-1025
12. Maestrelli F., Gonzalez-Rodriguez M.L., Rabasco A.M., and Mura P. Effect of preparationtechnique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int. J. Pharm. 312 (2006) 53-60
13. McCormack B., and Gregoriadis G. Comparative studies of the fate of free and liposome-entrapped hydropropyl-β-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim. Biophys. Acta 1291 (1996) 237-244
14. McCormack B., and Gregoriadis G. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J. Drug Target. 2 (1994) 449-454
15. New R., and Liposomes R. A Practical Approach (1990), Oxford University Press, Oxford
16. Nishijo J., and Mizuno H. Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies. Chem. Pharm. Bull. (Tokyo) 46 1 (1998) 120-124
17. Nishijo J., Shiota S., Mazima K., Inoue Y., Mizuno H., and Yoshida J. Interactions of cyclodextrins with dipalmitoyl, distearoyl, and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes. Chem. Pharm. Bull. 48 (2000) 48-52
18. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., and Delattre L. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int. J. Pharm. 312 (2006) 75-82
19. Puglisi G., Fresta M., and Ventura C.A. Interaction of natural and modified β-cyclodextrins with biological membrane model of dipalmitoylphosphatidylcholine. J. Colloid Interface Sci. 180 (1996) 542-547
20. Stewart J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104 (1980) 10-14
21. Takino T., Konishi K., Takakura Y., and Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol. Pharm. Bull. 17 (1994) 121-125